Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future vaccines and a global perspective

S L Katz1

  • 1Division of Pediatric infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.

Lancet (London, England)
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inter-rater reliability of video clips to assess for obstructive sleep apnea in children.

Sleep medicine·2025
Same author

Geographic disparities in performance of pediatric polysomnography to diagnose obstructive sleep apnea in a universal access health care system.

International journal of pediatric otorhinolaryngology·2021
Same author

A quieting ocean: unintended consequence of a fluctuating economy.

The Journal of the Acoustical Society of America·2012
Same author

Scale and pattern of broadnose sevengill shark Notorynchus cepedianus movement in estuarine embayments.

Journal of fish biology·2012
Same author

The clinical reaction of Nigerian children to measles vaccine with and without gamma globulin.

The Journal of hygiene·2010
Same author

John F. Enders and measles virus vaccine--a reminiscence.

Current topics in microbiology and immunology·2009
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
See all related articles

Medical biotechnology advances offer vaccines for over 75 infectious diseases. Challenges in resources and infrastructure hinder global immunization, but future strategies like mucosal vaccines and plant-based delivery show promise.

Area of Science:

  • Medical Biotechnology
  • Infectious Disease Control
  • Vaccinology

Background:

  • Vaccine development has advanced significantly, with potential for over 75 infectious diseases.
  • Global immunization efforts face significant hurdles, including resource limitations and inadequate healthcare infrastructure in developing nations.
  • Charitable organizations play a crucial role, but the scale of the challenge remains immense.

Purpose of the Study:

  • To review the current state of vaccine development and global immunization challenges.
  • To explore future possibilities and innovative approaches for vaccine administration and delivery.
  • To assess the prospects for infectious disease control and eradication in the upcoming century.

Main Methods:

  • Review of advancements in medical biotechnology for vaccine development.

Related Experiment Videos

  • Analysis of political, economic, and infrastructural factors affecting vaccine accessibility.
  • Exploration of novel vaccine delivery systems, including mucosal immunization and plant-based vaccines.

    • Main Results:

    • Over 75 infectious diseases have vaccine candidates or approved vaccines.
    • Significant disparities exist in vaccine production and accessibility between high- and low-income countries.
    • Emerging strategies like mucosal immunization and plant-derived vaccines offer potential economic and safety benefits.

    Conclusions:

    • Despite current challenges, future prospects for controlling and eradicating infectious diseases are positive.
    • Continued innovation in vaccine technology and delivery systems is essential for global health equity.
    • Addressing resource and infrastructure limitations is critical for maximizing the impact of vaccination programs worldwide.